Last updated: May 18, 2016
|CMS Measure ID:||CMS144v3|
Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed beta-blocker therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge
|Initial Patient Population:||
All patients aged 18 years and older with a diagnosis of heart failure
Equals Initial Patient Population with a current or prior LVEF < 40%
Patients who were prescribed beta-blocker therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge
|Measure Steward:||American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)|
|National Quality Strategy Domain:||Effective Clinical Care|
|Next Version:||Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)|
Higher score indicates better quality
LVEF < 40% corresponds to qualitative documentation of moderate dysfunction or severe dysfunction.
To meet this measure, it must be reported for all heart failure patients a minimum of once during the measurement period when seen in the outpatient setting AND reported at each hospital discharge during the measurement period.
-For patients with prior LVEF < 40%, beta-blocker therapy should include bisoprolol, carvedilol, or sustained release metoprolol succinate.
The requirement of Count >=2 of Encounter, Performed is to establish that the eligible professional has an existing relationship with the patient.